<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Polymorphisms rs1800587 and rs1143634 of the interleukin-1α gene are associated with the progression of carotid atherosclerosis in Caucasians with type 2 diabetes mellitus</dc:title><dc:creator>Pleskovič,	Aleš	(Avtor)
	</dc:creator><dc:creator>Nikolajević,	Jovana	(Avtor)
	</dc:creator><dc:creator>Mankoč Ramuš,	Sara	(Avtor)
	</dc:creator><dc:creator>Cilenšek,	Ines	(Avtor)
	</dc:creator><dc:creator>Šantl-Letonja,	Marija	(Avtor)
	</dc:creator><dc:creator>Makuc,	Jana	(Avtor)
	</dc:creator><dc:creator>Cokan Vujkovac,	Andreja	(Avtor)
	</dc:creator><dc:creator>Petrovič,	Danijel	(Avtor)
	</dc:creator><dc:subject>carotid atherosclerosis</dc:subject><dc:subject>genetic polymorphism</dc:subject><dc:subject>interleukin-1 α</dc:subject><dc:subject>cross-sectional study</dc:subject><dc:description>Background: Our study was designed to test the possible association between either polymorphisms T889C (rs1800587) or C3954T (rs1143634) of the interleukin-1 alpha (IL-1α) gene with subclinical markers of carotid atherosclerosis in patients with type 2 diabetes mellitus (T2DM). Moreover, the effect of both polymorphisms on progression of carotid atherosclerosis in 3.8-year follow-up was studied. Patients and methods: 595 subjects with T2DM were enrolled in the prospective study. Subclinical markers of carotid atherosclerosis were assessed with ultrasound at the time of recruitment and after 3.8-years. Genotyping of two polymorphisms (rs1800587, rs1143634) was performed with real-time PCR System. Results: The comparison of atherosclerosis parameters was performed with regard to different genotypes of IL-1α rs1800587 and rs1143634 polymorphisms upon enrolment. Multiple linear regression analysis revealed the association of IL-1α rs1143634 on total plaque thickness progression in a 3.8 year follow up. Conclusions: An association between either the IL-1α rs1800587 or rs1143634 and total plaque thickness at the time of recruitment was reported. Additionally, we demonstrated the effect of the IL-1α rs1143634 on total plaque thickness progression in the 3.8-year follow-up in patients with T2DM.</dc:description><dc:date>2016</dc:date><dc:date>2026-01-12 15:08:34</dc:date><dc:type>Neznano</dc:type><dc:identifier>25147</dc:identifier><dc:identifier>UDK: 61</dc:identifier><dc:identifier>ISSN pri članku: 2475-3211</dc:identifier><dc:identifier>DOI: 10.4172/2475-3211.1000113</dc:identifier><dc:identifier>COBISS_ID: 263106563</dc:identifier><dc:language>sl</dc:language><dc:rights>V članku navedeno: "This is an open-access article distributed under the terms of the Creative Commons Attribution License." Na spletni strani revije navedeno: "Creative Commons License CC BY-NC-ND 4.0" (https://www.hilarispublisher.com/policies.html. 12. 1. 2026).</dc:rights></metadata>
